Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Standard Medical Treatment Plus Endovascular Treatment Versus Standard Medical Treatment Alone for Stroke Patient With Large Vessel Occlusion In The Posterior Circulation: A Multicenter, Randomized, Clinical Trial

NCT04743076 is registered in ClinicalTrials.gov with Xinqiao Hospital of Chongqing as lead sponsor.

NCT NCT04743076
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04743076 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Standard Medical Treatment Plus Endovascular Treatment Versus Standard Medical Treatment Alone for Stroke Patient With Large Vessel Occlusion In The Posterior Circulation: A Multicenter, Randomized, Clinical Trial
Lead sponsor
Xinqiao Hospital of Chongqing
Phase
Not applicable
Overall status
Suspended
Start date
March 16, 2021
Completion date
May 16, 2024
Enrollment
386 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

vertebrobasilar stroke